Treatment of warfarin-associated coagulopathy with oral vitamin K: A randomised controlled trial

Lancet

Volumn 356, Issue 9241, 2000, Pages 1551-1553

  Crowther, Mark A ^a,d   Julian, Jim ^a,b   McCarty, Donna ^b   Douketis, James ^a   Kovacs, Michael ^c   Biagoni, Lee ^b   Schnurr, Terri ^b   McGinnis, Joanne ^b   Gent, Michael ^a,b   Hirsh, Jack ^a,b   Ginsberg, Jeff ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d ST JOSEPH S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL STANDARD UNIT; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; THROMBOSIS;

EID: 0034605685     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03125-1     Document Type: Note

References (8)

1. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation
2. Bleeding in outpatients treated with warfarin: Relation to the prothrombin time and important remedial lesions
3. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: The AFASAK 2 study: Atrial fibrillation aspirin and anticoagulation
4. Oral anticoagulant therapy in patients with coronary artery disease: A meta-analysis
5. Conservative treatment of overanticoagulated patients
6. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin
7. Reversal of excessive effect of regular anticoagulation: Low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation
8. Correction of excessive anticoagulation with low-dose oral vitamin K1